OTC Market Europe Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers OTC Pharmaceutical Companies is Segmented by Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels), and Geography (United Kingdom, Germany, Italy, France, Spain, and Rest of Europe). The report offers the market sizes and forecasts in terms of value (in USD million) for the above segments.

OTC Market Europe Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

OTC Europe Market Size

View Global Report
Europe Over-the-Counter (OTC) Drugs Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 5.40 %
Market Concentration Medium

Major Players

Europe Over-the-Counter (OTC) Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Over-the-counter (OTC) Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

OTC Europe Market Analysis

The Europe Over-the-counter Drugs Market is expected to register a CAGR of 5.4% during the forecast period.

The European OTC drugs landscape is significantly influenced by the region's aging demographic profile, with Eurostat reporting that 20.8% of the EU population was aged 65 years and above in 2021, with Finland leading at 22.7% of its population in this age bracket. This demographic shift has prompted pharmaceutical companies to adapt their product portfolios and distribution strategies to better serve the elderly population's needs, particularly in therapeutic areas such as pain management, sleep aids, and digestive health. The increasing healthcare costs and pressure on public health systems have led to a greater emphasis on preventive care and self-management of minor ailments, transforming how consumers approach healthcare decisions.


The distribution landscape for over-the-counter medicines continues to evolve, with retail pharmacies maintaining their dominant position while e-commerce channels gain significant traction. The emergence of omnichannel strategies has become increasingly prominent, with traditional pharmacy chains developing integrated online platforms to complement their physical presence. This transformation has been particularly evident in 2023, with major pharmacy retailers investing heavily in digital infrastructure and last-mile delivery capabilities to enhance accessibility and convenience for consumers.


Industry consolidation and strategic repositioning have characterized the OTC market in 2023, with several significant developments reshaping the competitive landscape. In July 2023, STADA Arzneimittel AG announced plans to purchase additional consumer health brands across multiple European countries, while Bausch + Lomb Corporation expanded its OTC product line through the acquisition of Blink Eye Drops from Johnson and Johnson. These strategic moves reflect the industry's focus on portfolio optimization and market expansion through targeted acquisitions.


The therapeutic needs of European consumers have shown notable evolution, particularly in dermatological conditions, where studies indicate that approximately 94 million Europeans reported uncomfortable skin sensations like itch, burning, or dryness in 2022. Consumer behavior has shifted towards a more proactive approach to health management, with 47.9% of the European general population reporting at least one dermatological condition in the past year. This trend has prompted manufacturers to develop more specialized OTC products targeting specific therapeutic areas and symptoms, leading to increased market segmentation and product differentiation.

Segment Analysis: By Product Type

Cough, Cold, and Flu Products Segment in Europe OTC Drugs Market

The cough, cold, and flu products segment dominates the European OTC segment, commanding approximately 27% of the market share in 2024. This segment's leadership position is primarily driven by the widespread distribution of these OTC products in the region for treating cold symptoms. The segment's growth is fueled by increasing self-medication practices for common respiratory ailments and the rising prevalence of cold and flu cases across European countries. The segment benefits from strong consumer awareness and easy accessibility through various distribution channels, including retail pharmacies and online platforms. Additionally, the continuous launch of new formulations and variants by key market players has helped maintain this segment's dominant position. The segment's robust performance is further supported by the increasing consumer preference for OTC solutions for managing common cold symptoms, coupled with the growing trend of preventive healthcare practices among European consumers.

Market Analysis of Europe Over-the-counter (OTC) Drugs Market: Chart for By Product Type

Remaining Segments in Europe OTC Drugs Market Product Types

The European OTC drug market encompasses several other significant segments that contribute to its overall growth. Analgesics represent a substantial portion of the market, serving the growing demand for pain management solutions. The gastrointestinal products segment addresses various digestive health concerns, while the vitamins, minerals, and supplements (VMS) segment caters to the increasing focus on preventive healthcare and wellness. Dermatology products serve various skin-related conditions, and ophthalmic products address eye health needs. The market also includes specialized segments such as weight-loss/dietary products and sleeping aids, which target specific consumer health needs. Each of these segments plays a crucial role in meeting diverse consumer healthcare requirements, supported by ongoing product innovations and expanding distribution networks across Europe.

Segment Analysis: By Distribution Channel

Retail Pharmacies Segment in Europe OTC Drugs Market

The retail pharmacies segment dominates the European over-the-counter (OTC) drugs market, holding approximately 43% of the market share in 2024. This significant market position is attributed to the widespread distribution of retail pharmacies across European countries and their role as one-stop shops for consumers to purchase all required OTC medicines. The segment's growth is driven by better outreach of this distribution channel, making it highly profitable across Europe. Companies actively support these retail pharmacies in their supply chain regulation, inventory management, expert consulting, and patient solution services to improve their competitiveness in the healthcare distribution network. The accessibility of retail pharmacies near homes and workplaces reduces long travel and waiting times for consumers, further strengthening their market position. Major pharmacy operators like PHOENIX group, which operates more than 2,700 pharmacies in 15 European countries, continue to expand their presence and enhance their service offerings.

Online Pharmacies Segment in Europe OTC Drugs Market

The online pharmacies segment is projected to experience the fastest growth rate of approximately 9% during the forecast period 2024-2029. This rapid expansion is driven by the increasing consumer preference for purchasing OTC products online, particularly following recent healthcare trends that have accelerated the adoption of digital solutions. The segment's growth is supported by advantages such as cost-effectiveness, easy availability, instant services, and round-the-clock accessibility. Countries like the United Kingdom and Germany are particularly focused on implementing and expanding online pharmacy services. The convenience of home delivery, broader product selection, and the ability to easily research and compare medicines online are key factors driving consumer adoption. Strategic partnerships between traditional pharmacies and e-commerce platforms are further accelerating the segment's growth, as companies seek to meet the rising demand for online pharmaceutical services.

Remaining Segments in Distribution Channel

The hospital pharmacies and other distribution channels segments continue to play vital roles in the European OTC drugs market. Hospital pharmacies benefit from their direct access to patient medication histories, enabling them to make personalized recommendations and ensure patient safety in OTC drug selection. These pharmacies are highly preferred by pharmaceutical companies for ensuring immediate availability of required medications, particularly given the high frequency of outpatient department visits. The other distribution channels, including nursing home pharmacies, direct selling, and medical center pharmacies, serve specific market niches and contribute to the overall accessibility of OTC medications. These channels are particularly important for serving specialized patient populations and providing targeted distribution solutions in various healthcare settings.

Europe Over-the-counter (OTC) Drugs Market Geography Segment Analysis

Over-the-Counter (OTC) Drugs Market in Germany

Germany dominates the European market for OTC drugs, commanding approximately 26% of the regional market share. The country's robust market position is supported by its highly regulated pharmaceutical industry and strong consumer awareness regarding self-medication practices. The German healthcare system's emphasis on preventive care and self-treatment has created a favorable environment for OTC products. The country's extensive network of pharmacies and drugstores ensures widespread accessibility of OTC medications to consumers. German consumers demonstrate a strong preference for established brands and high-quality products, particularly in categories such as cough and cold remedies, pain relievers, and digestive health products. The market is further strengthened by the presence of major pharmaceutical companies that maintain significant research and development facilities in the country. Additionally, the German regulatory framework, while stringent, provides clear guidelines for OTC drug classification and distribution, contributing to market stability and growth.

Over-the-Counter (OTC) Drugs Market in Sweden

Sweden represents one of the most dynamic markets in the European OTC drugs sector, projected to grow at approximately 6% annually from 2024 to 2029. The country's progressive healthcare policies and increasing consumer preference for self-medication are driving this robust growth. Swedish consumers demonstrate a strong inclination toward preventive healthcare and wellness products, particularly in categories such as vitamins and dietary supplements. The market benefits from a well-established distribution network, including both traditional pharmacies and modern retail channels. The Swedish Medical Products Agency's transparent regulatory framework has facilitated the introduction of new OTC products while maintaining high safety standards. The country's digital infrastructure has also enabled the growth of online pharmacy channels, making OTC products more accessible to consumers across various regions. Furthermore, Swedish consumers' high disposable income and willingness to invest in healthcare products contribute to the market's expansion.

Over-the-Counter (OTC) Drugs Market in France

France's OTC drugs market demonstrates strong performance, driven by the country's sophisticated healthcare infrastructure and evolving consumer preferences. The French market is characterized by a strong emphasis on quality and safety, with consumers showing particular interest in natural and organic OTC products. The country's pharmacies play a crucial role in the distribution of OTC medications, offering professional guidance and maintaining high standards of service. French consumers exhibit increasing awareness about self-medication and preventive healthcare, particularly in urban areas. The market benefits from continuous product innovations and the introduction of new formulations that cater to specific consumer needs. The French regulatory environment, while protective of consumer interests, has adapted to support the growth of the OTC sector. Additionally, the country's aging population and increasing focus on preventive healthcare contribute to sustained market growth.

Over-the-Counter (OTC) Drugs Market in United Kingdom

The United Kingdom's OTC drugs market exhibits strong fundamentals, supported by its advanced healthcare system and consumer-centric approach. The market benefits from a well-established pharmacy network and growing consumer confidence in self-medication practices. British consumers show increasing preference for convenient healthcare solutions, driving demand for OTC products across various therapeutic categories. The country's regulatory framework encourages the reclassification of prescription medicines to OTC status when appropriate, expanding market opportunities. The UK market is characterized by strong competition and continuous product innovation, leading to improved consumer choice and access. Digital transformation in the healthcare sector has facilitated the growth of online pharmacies, making OTC products more accessible to consumers. The market also benefits from robust marketing initiatives and consumer education programs that promote responsible self-medication.

Over-the-Counter (OTC) Drugs Market in Other Countries

The OTC drugs market in other European countries, including Spain, Denmark, Finland, Iceland, and Norway, demonstrates diverse growth patterns and market characteristics. These markets are influenced by their respective healthcare systems, regulatory frameworks, and consumer preferences. Southern European countries like Spain show increasing acceptance of self-medication practices, while Nordic countries maintain strict quality standards and emphasize consumer safety. These markets benefit from growing health awareness and increasing consumer preference for preventive healthcare solutions. The distribution landscape varies significantly across these countries, with some favoring traditional pharmacy channels while others embrace modern retail formats. Digital transformation and e-commerce adoption rates differ across these markets, influencing OTC product accessibility and consumer purchasing patterns. These countries also demonstrate varying levels of market maturity and consumer sophistication, leading to diverse growth opportunities across different product categories.

OTC Europe Industry Overview

Top Companies in Europe Over-the-Counter (OTC) Drugs Market

The European OTC drugs market features prominent players like Bayer AG, Reckitt Benckiser, Haleon, Johnson & Johnson, and Sanofi leading the competitive landscape through diverse product portfolios and strategic initiatives. Companies are increasingly focusing on technological advancements in production processes, particularly in areas like nanoparticle development for pain management products. The industry is witnessing a trend of major pharmaceutical companies spinning off their consumer healthcare divisions to create specialized OTC product-focused entities, exemplified by recent corporate restructuring moves. Market leaders are expanding their distribution networks through both traditional and digital channels, with a growing emphasis on e-commerce platforms and direct-to-consumer models. Innovation in product development, particularly in areas like respiratory health, pain management, and digestive health, remains a key competitive differentiator, while companies are also investing in sustainable manufacturing practices and digital transformation initiatives.

Consolidated Market with Strong Regional Players

The European OTC drugs market exhibits a blend of global pharmaceutical conglomerates and specialized regional players, creating a dynamic competitive environment. Global players leverage their extensive research capabilities and established brand portfolios, while regional specialists capitalize on their deep understanding of local markets and consumer preferences. The market structure is characterized by ongoing consolidation through mergers and acquisitions, particularly as companies seek to strengthen their positions in specific therapeutic categories or geographic regions. Private equity firms are showing increased interest in the sector, as demonstrated by ownership patterns of companies like STADA Arzneimittel AG.


The competitive landscape is further shaped by the presence of strong manufacturing capabilities across key European markets, particularly in Germany, France, and the United Kingdom. Companies are increasingly focusing on vertical integration strategies, controlling everything from production to distribution channels. The market also sees active participation from generic drug manufacturers who are expanding their OTC product portfolios through strategic acquisitions and licensing agreements. Cross-border partnerships and joint ventures are becoming more common as companies seek to expand their geographic reach and access new market segments while sharing development costs and risks.

Innovation and Digital Transformation Drive Success

For established players to maintain and expand their market share, a multi-faceted approach combining product innovation, digital transformation, and consumer engagement is essential. Companies need to invest in research and development to create differentiated products while also modernizing their manufacturing processes to improve efficiency and sustainability. The increasing importance of online sales channels necessitates strong digital capabilities and e-commerce presence. Market leaders must also focus on building strong relationships with healthcare professionals and pharmacists who play a crucial role in product recommendations while maintaining robust quality control systems to meet evolving regulatory requirements.


Emerging players can gain ground by focusing on niche therapeutic areas or specific regional markets where they can build strong brand recognition. Success factors include developing innovative formulations, establishing efficient supply chains, and creating strong distribution partnerships with both traditional and online retailers. Companies must also consider the growing importance of sustainability in packaging and production processes, as environmental consciousness becomes increasingly important to consumers. The regulatory environment, particularly regarding Rx-to-OTC switches and advertising restrictions, continues to shape market dynamics and create both opportunities and challenges for market participants. Building strong relationships with regulatory authorities and maintaining compliance with evolving standards remains crucial for long-term success. The role of OTC pharmaceutical distributors is becoming increasingly significant as they facilitate the efficient distribution of GSK OTC products and others, ensuring market reach and consumer accessibility.

OTC Europe Market Leaders

  1. Cardinal Health Inc.

  2. Bayer AG

  3. GlaxoSmithKline PLC

  4. Johnson & Johnson

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Europe Over-the-Counter (OTC) Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

OTC Europe Market News

  • In March 2022, Cymbiotika launched an e-commerce store in the United Kingdom for its range of natural supplements aimed at boosting consumer vitality and longevity.
  • In January 2022, P&G launched its highest strength Omega-3 under the Seven Seas brand in the United Kingdom.

OTC Europe Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Self-medication Practices
    • 4.2.2 Increasing New Product Launches
  • 4.3 Market Restraints
    • 4.3.1 High Probability of OTC Drug Abuse
    • 4.3.2 Lack of Awareness
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product Type
    • 5.1.1 Cough, Cold, and Flu Products
    • 5.1.2 Analgesics
    • 5.1.3 Dermatology Products
    • 5.1.4 Gastrointestinal Products
    • 5.1.5 Vitamins, Mineral, and Supplements (VMS)
    • 5.1.6 Weight-loss/Dietary Products
    • 5.1.7 Ophthalmic Products
    • 5.1.8 Sleeping Aids
    • 5.1.9 Other Product Types
  • 5.2 By Distribution Channel
    • 5.2.1 Hospital Pharmacies
    • 5.2.2 Retail Pharmacies
    • 5.2.3 Online Pharmacies
    • 5.2.4 Other Distribution Channels
  • 5.3 Geography
    • 5.3.1 Germany
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 Boehringer Ingelheim International GmbH
    • 6.1.3 Bristol Myers Squibb Company
    • 6.1.4 Cardinal Health Inc.
    • 6.1.5 GlaxoSmithKline PLC
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Merck & Co Inc.
    • 6.1.8 Sanofi SA
    • 6.1.9 Vitaris (Mylan NV)
    • 6.1.10 Pfizer Inc.
    • 6.1.11 Novartis AG
    • 6.1.12 Abbott Laboratories
    • 6.1.13 Perrigo Company PLC
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

OTC Europe Industry Segmentation

As per the scope of this report, over-the-counter (OTC) drugs are referred to as nonprescription drugs. These medicines can be bought by individuals without a doctor's prescription and are safe for consumption without the doctor's consent. The European over-the-counter drugs market is segmented by product type (cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals, and supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids, and other product types), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels), and geography (United Kingdom, Germany, Italy, France, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

By Product Type Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Distribution Channel Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

OTC Europe Market Research FAQs

What is the current Europe Over-the-counter (OTC) Drugs Market size?

The Europe Over-the-counter (OTC) Drugs Market is projected to register a CAGR of 5.4% during the forecast period (2025-2030)

Who are the key players in Europe Over-the-counter (OTC) Drugs Market?

Cardinal Health Inc., Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson and Novartis AG are the major companies operating in the Europe Over-the-counter (OTC) Drugs Market.

What years does this Europe Over-the-counter (OTC) Drugs Market cover?

The report covers the Europe Over-the-counter (OTC) Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Over-the-counter (OTC) Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Over-the-counter (OTC) Drugs Market Research

Mordor Intelligence provides a comprehensive analysis of the European market for over-the-counter medicines and nonprescription drugs. Our extensive research covers the full range of OTC products, from pharmaceutical distributors to retail channels across Europe. The report offers detailed OTC market data and analysis, examining the entire scope of OTC medicine categories. It also highlights emerging trends in OTC drug distribution and consumption patterns. Our expert analysts track OTC market size metrics and evaluate the significance of OTC drugs across various European regions.

Stakeholders gain from our thorough examination of OTC market trends and OTC segment performance indicators. The report provides valuable insights into OTC market expansion opportunities and the challenges facing OTC industry participants. Our analysis includes comprehensive OTC data on major markets, with a specific focus on developments in the pharma e-commerce market in Europe. The report, available as a downloadable PDF, presents actionable intelligence on the sale of OTC drugs and distribution networks. This enables businesses to make informed strategic decisions. Our research methodology ensures accurate forecasting and trend analysis, supporting both established players and new entrants in the over-the-counter market.

Europe OTC Market Report Snapshots